Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Shexiang Chifeng pain relief ointment is a topical traditional Chinese medicine (TCM) formulation used for the relief of pain associated with musculoskeletal conditions, including knee osteoarthritis, rheumatism, and muscle strains. The ointment typically contains a combination of active ingredients such as artificial musk, methyl salicylate, menthol, and camphor. These components provide analgesic and anti-inflammatory effects through local absorption; methyl salicylate acts as a counter-irritant and salicylate-based analgesic, while menthol and camphor provide cooling and soothing sensations by modulating sensory nerve receptors. In clinical studies, such as those conducted at Jiangsu Shengze Hospital, it has been evaluated as an adjunct therapy to standard treatments like diclofenac and ultra-short wave therapy to enhance pain management and improve joint function in patients with knee osteoarthritis.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on shexiang chifeng pain relief ointment.